Column Group LLC - Q2 2021 holdings

$707 Million is the total value of Column Group LLC's 5 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 16.7% .

 Value Shares↓ Weighting
NGM  NGM Biopharmaceuticals Inc$303,611,000
-32.2%
15,396,1160.0%42.97%
+0.2%
RAPT  RAPT Therapeutics Inc$123,526,000
+43.2%
3,885,6790.0%17.48%
+111.5%
RVMD SellRevolution Medicines Inc$106,242,000
-35.3%
3,347,245
-6.5%
15.04%
-4.4%
CNST  Constellation Pharmaceuticals Inc.$88,780,000
+44.5%
2,626,6310.0%12.57%
+113.5%
ORIC  ORIC Pharmaceuticals Inc.$84,349,000
-27.8%
4,768,1810.0%11.94%
+6.7%
NRIX ExitNurix Therapeutics Inc$0-5,383,333
-100.0%
-16.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NGM Biopharmaceuticals Inc12Q3 202352.5%
Revolution Medicines Inc12Q3 202336.3%
RAPT Therapeutics Inc12Q3 202329.6%
ORIC Pharmaceuticals Inc.12Q3 202314.6%
Tenaya Therapeutics, Inc.9Q3 202324.2%
Surrozen, Inc.9Q3 20238.2%
eFFECTOR Therapeutics Inc9Q3 20236.9%
Constellation Pharmaceuticals Inc.3Q2 202112.6%
Nurix Therapeutics Inc2Q1 202116.1%
Gritstone Oncology Inc1Q4 20200.3%

View Column Group LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-13
13F-HR2023-07-24
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
42022-05-27
42022-05-25
13F-HR2022-05-16

View Column Group LLC's complete filings history.

Compare quarters

Export Column Group LLC's holdings